Monica Fradkin on Improving Staff Communication for Patients in Clinical Trials
Monica Fradkin, RN, MPH, Smilow Cancer Hospital at Yale-New Haven, discusses improving communication between clinical staff and research staff for patients who are approved for clinical trials.
Monica Fradkin, RN, MPH, Smilow Cancer Hospital at Yale-New Haven, discusses improving communication between clinical staff and research staff for patients who are approved for clinical trials.
A cross-organizational communication system was established between the hospital and Yale with the common goal of safely treating patients in clinical trials and providing high-quality research care.
To accomplish this, a number of aspects were established, such as hand-off tools, clinical staff education, and documentation tools in the electronic medical records. Also, there is now better communication between the two institutions, ensuring that any information on new clinical trials is given to the treating nurses whose patients may be eligible.
UGN-102 Produces Comparable Responses Regardless of Surgery in NMIBC Subset
May 8th 2024Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery.
Verification Nurse Provides ‘Significant Contribution to Patient Safety’ During Chemo Administration
May 1st 2024The role of a verification nurse can lead to several benefits, including the prevention of errors from reaching the patient, decreased workload, and potential cost savings from less drug waste.
